Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 14, 1999

View Archived Issues

Incara to sell antibacterial division, concentrate on other programs

Phytopharm achieves success across all program areas during 1999

Chinese university researchers design new series of bronchodilators

Ligand submits NDA for Targretin Gel as CTCL therapy

Cambridge Drug Discovery teams up with universities to exploit protein-targeting technology

Successful phase II trial of Milkhaus cystic fibrosis product

Selective dopamine D3 receptor ligands for CNS disorders

Guilford receives milestone payment from Amgen for neuroimmunophilin IND filing

Vitex and Pentose complete merger

Selectus successfully completes phase IIb trial of beta-blocker

New AHP agents for insulin resistance and hyperglycemia

Janssen patents broad-spectrum azole antifungals with improved characteristics

Diversa and TerraGen Discovery crosslicense patents

NIH-sponsored study fails to confirm efficacy of secretin in autism

Novel truncated indolicidin analogues display broad-spectrum antimicrobial activity

Angiotensin II antagonists with isoquinoline structure discovered at Chinese university

Optimal dose discerned for clinprost in arteriosclerosis obliterans

Quark Biotech, Taisho investigate new treatments for renal disease

SS-cream increases ejaculatory latency and satisfaction in patients with premature ejaculation

Cell Genesys receives payment from Japan Tobacco for cancer vaccine milestone

Novartis obtains mutual recognition for Trileptal in E.U.

FDA requires additional phase III studies for Coactinon

Agouron's AG-7088 successfully completes phase II rhinovirus trial

7-Nitroindazole provides protection against focal ischemic injury in rat model

New analgesic is one million times more potent than morphine

Preclinical results in ovariectomized aged rats indicate beneficial effects on bone for Indian SERM

Bayer's Avelox approved in U.S. for treatment of respiratory illnesses

Favorable effects on cognition demonstrated in rats for Indian plant extract

StressGen's new treatment for cervical dysplasia successfully completes phase I study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...